What is the optimal strategy of prehospital pretreatment of STEMI patients with P2Y12 inhibitors? Experience from Pilsner region in the years 2013-2014
2016
Abstract
Prehospital pretreatment of STEMI patients with P2Y12 inhibitors remains a controversial issue also in year 2016. At the end of the year 2012, Pilsner emergency medical service in cooperation with Cardiology department, University hospital Pilsen prepared treatment protocol based on 2012 ESC guidelines for management of STEMI patients.
During 2013-2014, pre-hospital P2Y12 inhibitors were administered nearly in 50 % of STEMI patients. Ticagrelor was the most frequently used drug.